|
NZ207394A
(en)
|
1983-03-08 |
1987-03-06 |
Commw Serum Lab Commission |
Detecting or determining sequence of amino acids
|
|
WO1984003506A1
(en)
|
1983-03-08 |
1984-09-13 |
Commw Serum Lab Commission |
Antigenically active amino acid sequences
|
|
US4708871A
(en)
|
1983-03-08 |
1987-11-24 |
Commonwealth Serum Laboratories Commission |
Antigenically active amino acid sequences
|
|
US4863940A
(en)
*
|
1984-07-26 |
1989-09-05 |
Rohm And Haas |
N-acetonyl-substituted amides and phytopathogenic fungicidal use thereof
|
|
NZ215865A
(en)
|
1985-04-22 |
1988-10-28 |
Commw Serum Lab Commission |
Method of determining the active site of a receptor-binding analogue
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
US5571689A
(en)
|
1988-06-16 |
1996-11-05 |
Washington University |
Method of N-acylating peptide and proteins with diheteroatom substituted analogs of myristic acid
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5663143A
(en)
|
1988-09-02 |
1997-09-02 |
Dyax Corp. |
Engineered human-derived kunitz domains that inhibit human neutrophil elastase
|
|
WO1990007329A1
(en)
|
1989-01-06 |
1990-07-12 |
The Regents Of The University Of California |
Selection method for pharmacologically active compounds
|
|
IE910847A1
(en)
|
1990-03-13 |
1991-09-25 |
Fisons Plc |
Immunosuppressive macrocyclic compounds
|
|
ATE176239T1
(de)
|
1990-11-21 |
1999-02-15 |
Iterex Pharma Lp |
Synthese äquimolarer mischungen vielzähliger oligomere, speziell oligopeptidmischungen
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
WO1992013549A1
(en)
|
1991-02-07 |
1992-08-20 |
Research Corporation Technologies, Inc. |
Inhibition of cell proliferation by hydrophobic peptides
|
|
SE9102462D0
(sv)
|
1991-08-28 |
1991-08-28 |
Astra Ab |
New isosteric peptides
|
|
EP0541946B1
(de)
|
1991-10-07 |
1996-07-17 |
Hoechst Aktiengesellschaft |
Verfahren zur diastereoselektiven reduktiven Pinakol-Kupplung von homochiralen alpha-Aminoaldehyden
|
|
US5644048A
(en)
|
1992-01-10 |
1997-07-01 |
Isis Pharmaceuticals, Inc. |
Process for preparing phosphorothioate oligonucleotides
|
|
WO1994000095A2
(en)
|
1992-06-24 |
1994-01-06 |
Cortex Pharmaceuticals, Inc. |
Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
|
|
US5658885A
(en)
|
1993-04-27 |
1997-08-19 |
The Dupont Merck Pharmaceutical Company |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
|
|
WO1995009859A1
(en)
|
1993-10-07 |
1995-04-13 |
The Du Pont Merck Pharmaceutical Company |
Boropeptide inhibitors of thrombin which contain a substituted pyrrolidine ring
|
|
ATE377006T1
(de)
|
1995-11-28 |
2007-11-15 |
Cephalon Inc |
Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
|
|
DE19642591A1
(de)
|
1996-10-15 |
1998-04-16 |
Basf Ag |
Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung
|
|
WO1998021186A1
(en)
|
1996-11-13 |
1998-05-22 |
Cephalon, Inc. |
Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
|
|
DE19648793A1
(de)
|
1996-11-26 |
1998-05-28 |
Basf Ag |
Neue Benzamide und deren Anwendung
|
|
US5952322A
(en)
|
1996-12-05 |
1999-09-14 |
Pfizer Inc. |
Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
|
|
DE19650975A1
(de)
|
1996-12-09 |
1998-06-10 |
Basf Ag |
Neue heterocyclisch substituierte Benzamide und deren Anwendung
|
|
PL334059A1
(en)
|
1996-12-11 |
2000-01-31 |
Basf Ag |
Ketone benzamides useful as calpain inhibitors
|
|
US6100267A
(en)
|
1997-03-14 |
2000-08-08 |
Smithkline Beecham Corporation |
Quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
|
|
CA2284041C
(en)
|
1997-03-14 |
2010-05-18 |
Smithkline Beecham Corporation |
Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
|
|
US6083944A
(en)
|
1997-10-07 |
2000-07-04 |
Cephalon, Inc. |
Quinoline-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6150378A
(en)
|
1997-10-07 |
2000-11-21 |
Cephalon, Inc. |
Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
AU2960599A
(en)
|
1998-03-30 |
1999-10-18 |
Akira Karasawa |
Quinazoline derivatives
|
|
PL343495A1
(en)
*
|
1998-04-20 |
2001-08-27 |
Basf Ag |
Heterocyclically substituted amides used as calpain inhibitors
|
|
DE19817459A1
(de)
*
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue heterozyklische substituierte Amide, Herstellung und Anwendung
|
|
DE19818614A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Amide, deren Herstellung und Anwendung
|
|
TR200003071T2
(tr)
|
1998-04-20 |
2001-04-20 |
Basf Aktiengesellschaft |
Sistein-proteazı önleyici etkiye sahip yeni heterosiklik ikame edilmiş amidler
|
|
DE19817461A1
(de)
|
1998-04-20 |
1999-10-21 |
Basf Ag |
Neue substituierte Benzamide, deren Herstellung und Anwendung
|
|
CN1306505A
(zh)
|
1998-04-20 |
2001-08-01 |
Basf公司 |
新的取代酰胺、其制备以及应用
|
|
ATE524440T1
(de)
|
1998-05-25 |
2011-09-15 |
Abbott Gmbh & Co Kg |
Heterocyclische substituierte amide, deren herstellung und anwendung
|
|
US6335155B1
(en)
|
1998-06-26 |
2002-01-01 |
Sunesis Pharmaceuticals, Inc. |
Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules
|
|
US6280946B2
(en)
|
1998-08-07 |
2001-08-28 |
Boston Probes, Inc. |
PNA probes, probe sets, methods and kits pertaining to the universal detection of bacteria and eucarya
|
|
EP1141708A1
(en)
|
1998-12-28 |
2001-10-10 |
Sunesis Pharmaceuticals Inc. |
Identifying small organic molecule ligands for binding
|
|
JP2002539190A
(ja)
|
1999-03-15 |
2002-11-19 |
アクシス・ファーマシューティカルズ・インコーポレイテッド |
プロテアーゼ阻害剤としての新規化合物および組成物
|
|
HK1039108A1
(zh)
*
|
1999-03-15 |
2002-04-12 |
Axys Pharmaceuticals, Inc. |
以n-氰甲基酰胺作为蛋白酶抑制剂
|
|
EP1165490B1
(en)
*
|
1999-03-16 |
2006-08-16 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
|
NZ516348A
(en)
|
1999-06-23 |
2003-06-30 |
Aventis Pharma Gmbh |
Substituted benzimidazole
|
|
US6900207B2
(en)
|
2000-01-26 |
2005-05-31 |
Ono Pharmaceutical Co., Ltd. |
N-containing five-membered ring compounds and pharmaceutical agents comprising the same as active ingredient
|
|
EP1283728A2
(en)
|
2000-05-23 |
2003-02-19 |
Amersham Health AS |
Contrast agents
|
|
US6582827B1
(en)
|
2000-11-27 |
2003-06-24 |
The Trustees Of Columbia University In The City Of New York |
Specialized substrates for use in sequential lateral solidification processing
|
|
DE10114762A1
(de)
|
2001-03-26 |
2002-10-02 |
Knoll Gmbh |
Verwendung von Cysteinprotease-Inhibitoren
|
|
CA2936534C
(en)
|
2001-07-23 |
2021-01-26 |
The Board Of Trustees Of Leland Stanford Junior University |
Methods and compositions for rnai mediated inhibition of gene expression in mammals
|
|
US6878743B2
(en)
|
2001-09-18 |
2005-04-12 |
Sunesis Pharmaceuticals, Inc. |
Small molecule inhibitors of caspases
|
|
US20030167490A1
(en)
|
2001-11-26 |
2003-09-04 |
Hunter Craig P. |
Gene silencing by systemic RNA interference
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
NZ534238A
(en)
|
2002-01-31 |
2006-09-29 |
Morphochem Ag Komb Chemie |
Compounds that inhibit factor Xa activity
|
|
KR100838333B1
(ko)
|
2002-04-25 |
2008-06-13 |
오노 야꾸힝 고교 가부시키가이샤 |
디케토히드라진 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
|
|
EP1546089A2
(en)
|
2002-08-09 |
2005-06-29 |
TransTech Pharma Inc. |
Aryl and heteroaryl compounds and methods to modulate coagulation
|
|
KR101076018B1
(ko)
|
2003-01-08 |
2011-10-21 |
유니버시티 오브 워싱톤 |
항균제
|
|
US20040242542A1
(en)
|
2003-03-25 |
2004-12-02 |
The Regents Of The University Of California |
Compositions and methods for inducing CD81 dependent antiproliferation and for treating hepatitis C and other disorders
|
|
WO2005000793A1
(ja)
|
2003-06-26 |
2005-01-06 |
Taisho Pharmaceutical Co., Ltd. |
２位置換シクロアルキルカルボン酸誘導体
|
|
EP1493739A1
(fr)
|
2003-07-03 |
2005-01-05 |
Warner-Lambert Company LLC |
Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
WO2005014006A1
(en)
|
2003-07-21 |
2005-02-17 |
Novartis Ag |
Combinations of a cathepsin k inhibitor and a bisphophonate in the treatment of bone metastasis, tumor growth and tumor-induced bone loss
|
|
US7459472B2
(en)
|
2003-08-08 |
2008-12-02 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
CA2535337A1
(en)
|
2003-08-14 |
2005-03-03 |
Merck & Co., Inc. |
Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
EP1741441A4
(en)
|
2004-04-26 |
2010-03-03 |
Ono Pharmaceutical Co |
BONE-ENHANCING AGENT CHARACTERIZED BY USING CATHEPSIN K INHIBITOR WITH PTH
|
|
JP2008519761A
(ja)
|
2004-11-09 |
2008-06-12 |
スミスクライン ビーチャム コーポレーション |
グリコーゲンホスホリラーゼ阻害化合物およびその医薬組成物
|
|
WO2006078942A2
(en)
|
2005-01-21 |
2006-07-27 |
President And Fellows Of Harvard College |
Regulation of protein synthesis by inhibition of eif4e-eif4g interaction
|
|
US20080311036A1
(en)
|
2005-05-11 |
2008-12-18 |
University Of Florida Research Foundation, Inc. |
Imaging of Neural and Organ Injury or Damage
|
|
JP2009503084A
(ja)
|
2005-08-01 |
2009-01-29 |
フェノミックス コーポレーション |
Ｃ型肝炎セリンプロテアーゼ阻害剤およびその使用
|
|
US7964624B1
(en)
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
|
JP2009521504A
(ja)
|
2005-12-22 |
2009-06-04 |
スミスクライン・ビーチャム・コーポレイション |
Ａｋｔ活性阻害剤
|
|
WO2007081530A2
(en)
|
2006-01-03 |
2007-07-19 |
Med Institute, Inc. |
Endoluminal medical device for local delivery of cathepsin inhibitors
|
|
WO2007089618A2
(en)
|
2006-01-27 |
2007-08-09 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
|
JP2009526854A
(ja)
|
2006-02-16 |
2009-07-23 |
エスエムエイ ファンデーション |
脊髄性筋萎縮症を治療するためのユビキチン／プロテアソーム阻害剤
|
|
EP2194039A1
(en)
|
2006-03-16 |
2010-06-09 |
Vertex Pharmceuticals Incorporated |
Process for preparing optically enriched compounds
|
|
US20080045521A1
(en)
|
2006-06-09 |
2008-02-21 |
Astrazeneca Ab |
Phenylalanine derivatives
|
|
US8710178B2
(en)
|
2006-10-18 |
2014-04-29 |
Lincoln University |
Macrocyclic cysteine protease inhibitors and compositions thereof
|
|
PT2439205E
(pt)
|
2006-12-29 |
2015-07-16 |
Abbvie Deutschland |
Compostos de carboxamida e seus usos como inibidores de calpaína
|
|
CN101903392A
(zh)
|
2007-02-27 |
2010-12-01 |
弗特克斯药品有限公司 |
丝氨酸蛋白酶的抑制剂
|
|
CA2691987C
(en)
|
2007-06-12 |
2016-08-16 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2014657A1
(de)
|
2007-06-21 |
2009-01-14 |
Bayer Schering Pharma Aktiengesellschaft |
Diaminopyrimidine als Modulatoren des EP2-Rezeptors
|
|
TWI453019B
(zh)
|
2007-12-28 |
2014-09-21 |
Abbvie Deutschland |
甲醯胺化合物
|
|
TW201010700A
(en)
|
2008-08-25 |
2010-03-16 |
Piramal Lifesciences Ltd |
Diacylglycerol acyltransferase inhibitors
|
|
US8629157B2
(en)
|
2009-01-05 |
2014-01-14 |
Boehringer Ingelheim International Gmbh |
Pyrrolidine compounds which modulate the CB2 receptor
|
|
GB2467561A
(en)
|
2009-02-06 |
2010-08-11 |
Summit Corp Plc |
Dual calpain-ROS inhibitors
|
|
TWI519530B
(zh)
|
2009-02-20 |
2016-02-01 |
艾伯維德國有限及兩合公司 |
羰醯胺化合物及其作為鈣蛋白酶（ｃａｌｐａｉｎ）抑制劑之用途
|
|
US8236798B2
(en)
|
2009-05-07 |
2012-08-07 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors
|
|
US9051304B2
(en)
|
2009-12-22 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Carboxamide compounds and their use as calpain inhibitors V
|
|
US8598211B2
(en)
|
2009-12-22 |
2013-12-03 |
Abbvie Inc. |
Carboxamide compounds and their use as calpain inhibitors IV
|
|
CN102812167A
(zh)
|
2009-12-30 |
2012-12-05 |
阿维拉制药公司 |
蛋白的配体-介导的共价修饰
|
|
EP2560491A1
(en)
|
2010-04-21 |
2013-02-27 |
Signature Therapeutics, Inc. |
Peripheral opioid agonists and peripheral opioid antagonists
|
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
|
WO2011159781A2
(en)
|
2010-06-17 |
2011-12-22 |
Senomyx, Inc. |
Bitter taste modulators
|
|
US20120010235A1
(en)
|
2010-07-12 |
2012-01-12 |
Xin-Jie Chu |
N-substituted pyrrolidines
|
|
WO2012021788A2
(en)
|
2010-08-13 |
2012-02-16 |
Banyan Biomarkers |
Dipeptide calpain inhibitors
|
|
US9000025B2
(en)
|
2010-08-20 |
2015-04-07 |
Amira Pharmaceuticals, Inc. |
Autotaxin inhibitors and uses thereof
|
|
US20120095211A1
(en)
|
2010-09-22 |
2012-04-19 |
Intermune, Inc. |
Substituted proline inhibitors of hepatitis c virus replication
|
|
WO2012076639A1
(en)
|
2010-12-09 |
2012-06-14 |
Abbott Gmbh & Co. Kg |
Carboxamide compounds and their use as calpain inhibitors v
|
|
BR112013022946A2
(pt)
|
2011-03-09 |
2017-07-18 |
Signature Therapeutics Inc |
pró-fármacos de agentes ativos com ligantes heterocíclocos
|
|
US8685916B2
(en)
|
2011-03-09 |
2014-04-01 |
Signature Therapeutics, Inc. |
Opioid prodrugs with heterocyclic linkers
|
|
WO2012140500A1
(en)
|
2011-04-15 |
2012-10-18 |
New World Laboratories, Inc. |
Selective cysteine protease inhibitors and uses thereof
|
|
CN108383893A
(zh)
|
2011-08-30 |
2018-08-10 |
塔夫茨大学信托人 |
用于治疗实体瘤的fap-活化的蛋白酶体抑制剂
|
|
KR20140102253A
(ko)
|
2011-11-25 |
2014-08-21 |
에프. 호프만-라 로슈 아게 |
카텝신의 억제제로서의 피롤리딘 유도체
|
|
KR20140114827A
(ko)
|
2012-01-11 |
2014-09-29 |
에프. 호프만-라 로슈 아게 |
프로테아제 억제제로서 매크로사이클릭 아미드
|
|
EP2834230A1
(en)
|
2012-04-03 |
2015-02-11 |
AbbVie Deutschland GmbH & Co KG |
Carboxamide compounds and their use as calpain inhibitors v
|
|
EP2844249A4
(en)
|
2012-05-02 |
2016-03-09 |
Univ Kansas State |
MACROCYCLIC AND PEPTIDOMIMETIC COMPOUNDS AS VIRUZIDES AGAINST 3C OR 3C LIKE PROTEASES OF PICORNIVERS, CALICIVIRES AND CORONA VIRUSES
|
|
WO2014075146A1
(en)
|
2012-11-16 |
2014-05-22 |
Adelaide Research & Innovation Pty Ltd |
Macrocyclic compounds and uses thereof
|
|
TW201506024A
(zh)
|
2013-07-02 |
2015-02-16 |
必治妥美雅史谷比公司 |
作為有效ｒｏｃｋ抑制劑的三環甲醯胺衍生物
|
|
TW201605859A
(zh)
*
|
2013-11-14 |
2016-02-16 |
必治妥美雅史谷比公司 |
作為酪蛋白激酶１δ／ε抑制劑之新穎經取代之吡唑并－哌
|
|
EP3107952B1
(en)
|
2014-02-19 |
2018-09-26 |
ETH Zurich |
Method for the generation of chemical libraries
|
|
EP3119777A1
(de)
|
2014-03-21 |
2017-01-25 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
|
WO2015179441A2
(en)
|
2014-05-20 |
2015-11-26 |
Rqx Pharmaceuticals, Inc. |
Macrocyclic broad spectrum antibiotics
|
|
WO2015196086A1
(en)
|
2014-06-20 |
2015-12-23 |
The University of Montana, Missoula, MT |
NOVEL INHIBITORS OF SYSTEM Xc(-)
|
|
WO2016027284A2
(en)
|
2014-08-22 |
2016-02-25 |
Alkem Laboratories Ltd. |
Piperidine ureas as cathepsin cysteine protease inhibitors
|
|
ES2714283T3
(es)
|
2014-09-04 |
2019-05-28 |
Bristol Myers Squibb Co |
Macrociclos de diamida que son inhibidores de FXIa
|
|
US11219670B2
(en)
|
2014-09-05 |
2022-01-11 |
The Johns Hopkins University |
Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies
|
|
WO2016089648A1
(en)
|
2014-12-01 |
2016-06-09 |
Vtv Therapeutics Llc |
Bach 1 inhibitors in combination with nrf2 activators and pharmaceutical compositions thereof
|
|
ES2864839T3
(es)
|
2015-07-02 |
2021-10-14 |
Turning Point Therapeutics Inc |
Macrociclos de diarilo quirales como moduladores de proteína quinasas
|
|
US9938273B2
(en)
|
2015-12-07 |
2018-04-10 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
CN105669520B
(zh)
|
2016-01-12 |
2018-10-30 |
山东大学 |
含有色氨酸基本骨架的邻苯二胺类选择性组蛋白去乙酰化酶抑制剂及其制备方法和应用
|
|
WO2017156074A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Calpain modulators and methods of production and use thereof
|
|
WO2017156071A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
ES2965394T3
(es)
|
2016-06-29 |
2024-04-15 |
Univ California |
Compuestos y composiciones para el tratamiento del cáncer
|
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
WO2018064119A1
(en)
|
2016-09-28 |
2018-04-05 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
AU2018289434A1
(en)
|
2017-06-23 |
2020-01-16 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
US20210009564A1
(en)
|
2018-03-28 |
2021-01-14 |
Blade Therapertics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
CA3093749A1
(en)
|
2018-03-28 |
2019-10-03 |
Blade Therapeutics, Inc. |
Method of treating fibrotic disease
|
|
WO2019217465A1
(en)
|
2018-05-09 |
2019-11-14 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof background
|
|
CN112703188A
(zh)
|
2018-06-28 |
2021-04-23 |
布莱德治疗公司 |
用钙蛋白酶抑制剂治疗肝纤维化的方法
|
|
WO2020006177A1
(en)
|
2018-06-29 |
2020-01-02 |
Blade Therapeutics, Inc. |
Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereof
|